DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Yorifuji N, Inoue T, Iguchi M. et al.
The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
Oncol Rep 2016;
35: 676-682
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.